Följ
Derek Yellon
Derek Yellon
Professor of Molecular & Cellular Cardiology
Verifierad e-postadress på ucl.ac.uk
Titel
Citeras av
Citeras av
År
Myocardial reperfusion injury
DM Yellon, DJ Hausenloy
New England Journal of Medicine 357 (11), 1121-1135, 2007
46162007
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
DJ Hausenloy, DM Yellon
The Journal of clinical investigation 123 (1), 92-100, 2013
23272013
Preconditioning the myocardium: from cellular physiology to clinical cardiology
DM Yellon, JM Downey
Physiological reviews 83 (4), 1113-1151, 2003
14762003
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.
MS Marber, DS Latchman, JM Walker, DM Yellon
Circulation 88 (3), 1264-1272, 1993
14631993
New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
DJ Hausenloy, DM Yellon
Cardiovascular research 61 (3), 448-460, 2004
13702004
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion
MJA Walker, MJ Curtis, DJ Hearse, RWF Campbell, MJ Janse, DM Yellon, ...
Cardiovascular research 22 (7), 447-455, 1988
13701988
Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway
A Tsang, DJ Hausenloy, MM Mocanu, DM Yellon
Circulation research 95 (3), 230-232, 2004
11502004
Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.
MS Marber, R Mestril, SH Chi, MR Sayen, DM Yellon, WH Dillmann
The Journal of clinical investigation 95 (4), 1446-1456, 1995
10911995
Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury
SB Ong, S Subrayan, SY Lim, DM Yellon, SM Davidson, DJ Hausenloy
Circulation 121 (18), 2012-2022, 2010
10732010
Preconditioning the human myocardium
DM Yellon, AM Alkhulaifi, WB Pugsley
The Lancet 342 (8866), 276-277, 1993
10351993
Anthracycline chemotherapy and cardiotoxicity
JV McGowan, R Chung, A Maulik, I Piotrowska, JM Walker, DM Yellon
Cardiovascular drugs and therapy 31, 63-75, 2017
9752017
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial
DJ Hausenloy, PK Mwamure, V Venugopal, J Harris, M Barnard, ...
The Lancet 370 (9587), 575-579, 2007
9022007
Cardiovascular remodelling in coronary artery disease and heart failure
G Heusch, P Libby, B Gersh, D Yellon, M Böhm, G Lopaschuk, L Opie
The Lancet 383 (9932), 1933-1943, 2014
8292014
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
AK Bose, MM Mocanu, RD Carr, CL Brand, DM Yellon
Diabetes 54 (1), 146-151, 2005
8172005
Remote ischemic preconditioning and outcomes of cardiac surgery
DJ Hausenloy, L Candilio, R Evans, C Ariti, DP Jenkins, S Kolvekar, ...
New England Journal of Medicine 373 (15), 1408-1417, 2015
7982015
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
DJ Hausenloy, HL Maddock, GF Baxter, DM Yellon
Cardiovascular research 55 (3), 534-543, 2002
7892002
De novo cardiomyocytes from within the activated adult heart after injury
N Smart, S Bollini, KN Dubé, JM Vieira, B Zhou, S Davidson, D Yellon, ...
Nature 474 (7353), 640-644, 2011
7652011
Remote ischaemic preconditioning: underlying mechanisms and clinical application
DJ Hausenloy, DM Yellon
Cardiovascular research 79 (3), 377-386, 2008
7212008
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
DJ Hausenloy, DM Yellon
Heart failure reviews 12, 217-234, 2007
7162007
Remote ischemic conditioning
G Heusch, HE Bøtker, K Przyklenk, A Redington, D Yellon
Journal of the American College of Cardiology 65 (2), 177-195, 2015
6982015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20